Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP91908.RAwifkFXQLTw3N2WAv2S3fKbBvoeM90JVcmVgzM_CQvhg130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP91908.RAwifkFXQLTw3N2WAv2S3fKbBvoeM90JVcmVgzM_CQvhg130_assertion type Assertion NP91908.RAwifkFXQLTw3N2WAv2S3fKbBvoeM90JVcmVgzM_CQvhg130_head.
- NP91908.RAwifkFXQLTw3N2WAv2S3fKbBvoeM90JVcmVgzM_CQvhg130_assertion description "[, we can say that FV 1691 A and PT 20210 A mutations are important and must be included to the routine analysis of pediatric stroke patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP91908.RAwifkFXQLTw3N2WAv2S3fKbBvoeM90JVcmVgzM_CQvhg130_provenance.
- NP91908.RAwifkFXQLTw3N2WAv2S3fKbBvoeM90JVcmVgzM_CQvhg130_assertion evidence source_evidence_literature NP91908.RAwifkFXQLTw3N2WAv2S3fKbBvoeM90JVcmVgzM_CQvhg130_provenance.
- NP91908.RAwifkFXQLTw3N2WAv2S3fKbBvoeM90JVcmVgzM_CQvhg130_assertion SIO_000772 11323021 NP91908.RAwifkFXQLTw3N2WAv2S3fKbBvoeM90JVcmVgzM_CQvhg130_provenance.
- NP91908.RAwifkFXQLTw3N2WAv2S3fKbBvoeM90JVcmVgzM_CQvhg130_assertion wasDerivedFrom gad-20150221 NP91908.RAwifkFXQLTw3N2WAv2S3fKbBvoeM90JVcmVgzM_CQvhg130_provenance.
- NP91908.RAwifkFXQLTw3N2WAv2S3fKbBvoeM90JVcmVgzM_CQvhg130_assertion wasGeneratedBy ECO_0000203 NP91908.RAwifkFXQLTw3N2WAv2S3fKbBvoeM90JVcmVgzM_CQvhg130_provenance.